Vaccine Information from the NIAID

VACCINE: A substance that contains antigenic components from an infectious micro-organism. By stimulating an immune response -but not the disease-it protects against subsequent infection by that organism.

New HIV Binding Discovery Could Have Implications for Vaccine Development   2/20/07

Male Circumcision Reduces HIV Infection Risk Equivalent to a High Efficacy Vaccine - 10/31/05

NIAID Launches Phase II Trial of a New HIV/AIDS Vaccine - 10/17/05

Survey Uncovers Surprising Attitudes about HIV Vaccine Research - 8/10/05

GlaxoSmithKline Biologicals and AIDS Vaccine Initiative Partner to Develop AIDS Vaccine - 6/22/05

The Presence of Anti-Tat Antibodies Is Predictive of Long-Term Non Progression to AIDS or Severe Immunodeficiency - 4/06/05

Therapeutic Immunization May Curb HIV After HAART Is Stopped - 3/18/05

AIDS Pioneer Luc Montagnier Calls for Focus on 'Therapeutic' Vaccine - 3/14/05

US Belt Tightening Could Hit AIDS Efforts - 2/25/05

NIAID Seeks Applications from Institutions to Lead Clinical Trials Units for Revamped HIV/AIDS Trials Networks - 2/16/05

Imperfect  Vaccines Could Reduce HIV Prevalence and AIDS Deaths - 1/31/05

HIV Patch Vaccine Shows Promise in Animal Studies - 1/31/05

NIAID Begins Enrolling Volunteers for Novel HIV Vaccine Study - 1/26/05

Researchers Develop Strategic Plan for AIDS Vaccine Development - 1/19/05

New Vaccine Trial in New York Seeks Healthy Volunteers - 1/05/05